Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ketorolac tromethamine + isopropyl alcohol + povidone-iodine + lidocaine
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Topical, Infiltration, Intramuscular, Intravenous
01
Overview
Ketorolac tromethamine + isopropyl alcohol + povidone-iodine + lidocaine is a combination pharmaceutical kit marketed as **Ketorocaine L Kit**. It combines ketorolac tromethamine, a small-molecule nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase and reduces prostaglandin synthesis to provide opioid-level short-term analgesia for moderately severe acute pain, with lidocaine as a local anesthetic and povidone-iodine plus isopropyl alcohol as topical antiseptic components used in procedural preparation. Publicly described labeling associates the product with Asclemed USA for acute pain use, with administration routes including infiltration, intramuscular, intravenous, and topical use depending on component. The available context also indicates the kit labeling has not been approved by FDA and that the product has not been found by FDA to be safe and effective.
- Brand names
- Ketorocaine L Kit
- Other names
- ketorolac tromethamine + isopropyl alcohol + povidone-iodine + lidocaine
02
Targets
NaV (Voltage-gated sodium channels)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on ketorolac tromethamine + isopropyl alcohol + povidone-iodine + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ketorolac tromethamine + isopropyl alcohol + povidone-iodine + lidocaine.